• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒治疗初治的 HIV 感染年轻男性低骨密度的患病率和危险因素。

Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.

机构信息

Service de rhumatologie, CHU Lille, 59000 Lille, France; Université de Lille, université Littoral Côte d'Opale, PMOI EA 4490 faculté de chirurgie dentaire, place de Verdun, 59000 Lille, France.

Service des maladies infectieuses, centre hospitalier Tourcoing, CHU Lille, 59000 Lille, France.

出版信息

Med Mal Infect. 2018 Oct;48(7):442-448. doi: 10.1016/j.medmal.2018.02.009. Epub 2018 Apr 23.

DOI:10.1016/j.medmal.2018.02.009
PMID:29699830
Abstract

OBJECTIVE

We aimed to investigate the prevalence of low bone mineral density (BMD) and associated factors in antiretroviral therapy (ART)-naive HIV-infected young men.

METHODS

In this cross-sectional study, dual-energy X-ray absorptiometry (DXA) was used to measure BMD. BMD at the lumbar spine, total hip and femoral neck sites was expressed as a Z-score (number of standard deviations away from the mean in an age, race and sex-matched reference population). Low BMD was defined as Z-scores≤-2 at any of the three sites. The prevalence of low BMD was evaluated at the lumbar spine, total hip and femoral neck sites, as were risk factors associated with Z-scores.

RESULTS

The study cohort comprised 49 men, of whom 87.8% were white. Mean age was 31.6 (±7.7) years and mean BMI was 22.7 (±4.0)kg/m. Half of patients (51.0%) were current smokers. The prevalence of low BMD was 24.5% [95% CI, 13.3-38.9]. Low estradiol levels and low BMI were associated with low Z-scores at each skeletal site, whereas current smoking and high IGF1 levels were associated with low Z-scores at the lumbar spine site. Among the HIV-related factors, low CD4+ cell count was associated with low Z-scores at the lumbar spine site.

CONCLUSIONS

We observed a high prevalence of low BMD in our ART-naive cohort of young men. Risk factors associated with low Z-scores were those usually observed in HIV-infected individuals (low BMI, current smoking and CD4+ cell count) or linked to endocrine hormone levels (estradiol, IGF-1).

摘要

目的

我们旨在研究初治 HIV 感染年轻男性的低骨密度(BMD)患病率及其相关因素。

方法

在这项横断面研究中,采用双能 X 线吸收法(DXA)测量 BMD。腰椎、全髋和股骨颈部位的 BMD 以 Z 评分(与年龄、种族和性别匹配的参考人群平均值相差的标准差数)表示。任何部位的 Z 评分≤-2 定义为低 BMD。评估腰椎、全髋和股骨颈部位的低 BMD 患病率以及与 Z 评分相关的危险因素。

结果

研究队列包括 49 名男性,其中 87.8%为白人。平均年龄为 31.6(±7.7)岁,平均 BMI 为 22.7(±4.0)kg/m2。半数患者(51.0%)为当前吸烟者。低 BMD 的患病率为 24.5%[95%CI,13.3-38.9]。低雌二醇水平和低 BMI 与各骨骼部位的低 Z 评分相关,而当前吸烟和高 IGF1 水平与腰椎部位的低 Z 评分相关。在 HIV 相关因素中,低 CD4+细胞计数与腰椎部位的低 Z 评分相关。

结论

我们观察到我们的初治年轻男性队列中低 BMD 的患病率较高。与低 Z 评分相关的危险因素是 HIV 感染者中通常观察到的那些(低 BMI、当前吸烟和 CD4+细胞计数)或与内分泌激素水平相关的因素(雌二醇、IGF-1)。

相似文献

1
Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.抗逆转录病毒治疗初治的 HIV 感染年轻男性低骨密度的患病率和危险因素。
Med Mal Infect. 2018 Oct;48(7):442-448. doi: 10.1016/j.medmal.2018.02.009. Epub 2018 Apr 23.
2
Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.在意大利一家中心对HIV感染患者进行普遍双能X线吸收法(DXA)筛查后,低骨矿物质密度和脆性骨折的患病率及预测因素:当前骨矿物质密度管理指南的敏感性和特异性
AIDS Patient Care STDS. 2015 Apr;29(4):169-80. doi: 10.1089/apc.2014.0205. Epub 2015 Feb 18.
3
Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.未接受治疗的HIV感染者低骨矿物质密度的患病率及危险因素:INSIGHT抗逆转录病毒治疗策略性时机(START)试验的一项子研究
HIV Med. 2015 Apr;16 Suppl 1(0 1):137-46. doi: 10.1111/hiv.12242.
4
Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.HIV 感染、病毒学控制的年轻男性中降低的骨矿物质密度:患病率及相关因素。
AIDS. 2018 Nov 28;32(18):2689-2696. doi: 10.1097/QAD.0000000000002001.
5
Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.围产期感染艾滋病毒且病毒得到抑制的亚洲青少年中存在不良骨骼健康和异常骨转换情况。
HIV Med. 2017 Apr;18(4):235-244. doi: 10.1111/hiv.12418. Epub 2016 Aug 1.
6
Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.人类免疫缺陷病毒感染个体的骨密度降低:患病率及其危险因素的荟萃分析。
Osteoporos Int. 2018 Mar;29(3):595-613. doi: 10.1007/s00198-017-4305-8. Epub 2017 Nov 20.
7
Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.在未接受抗逆转录病毒治疗的 HIV 感染成年男性中,与较低骨密度相关的风险因素增加。
BMC Infect Dis. 2021 Jun 9;21(1):542. doi: 10.1186/s12879-021-06263-9.
8
Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.围生期感染人类免疫缺陷病毒的泰国青少年接受抗逆转录病毒治疗后低骨密度的流行率和危险因素。
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):477-83. doi: 10.1097/QAI.0b013e31826ea89b.
9
Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.未接受抗逆转录病毒治疗的成人人类免疫缺陷病毒感染者骨密度变化的患病率及危险因素:一项中国队列研究
Chin Med J (Engl). 2020 Dec 3;133(24):2940-2946. doi: 10.1097/CM9.0000000000001317.
10
Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.在接受联合抗逆转录病毒治疗的伴有骨质疏松症的 HIV-1 感染男性中,2 年内骨密度的变化。
AIDS. 2013 Sep 24;27(15):2425-30. doi: 10.1097/QAD.0b013e32836378c3.

引用本文的文献

1
Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning.使用机器学习方法研究接受含富马酸替诺福韦二吡呋酯方案抗逆转录病毒治疗的年轻HIV感染者的骨质流失情况。
Front Pharmacol. 2025 Apr 4;16:1516013. doi: 10.3389/fphar.2025.1516013. eCollection 2025.
2
Impact of different antiretroviral therapy regimens on bone mineral density in people living with HIV: a retrospective and longitudinal study in China.不同抗逆转录病毒治疗方案对HIV感染者骨矿物质密度的影响:一项中国的回顾性纵向研究
BMC Infect Dis. 2024 Dec 18;24(1):1400. doi: 10.1186/s12879-024-10299-y.
3
Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
HIV 感染者低骨密度的流行情况及相关因素:一项横断面研究。
Arch Osteoporos. 2024 Jul 2;19(1):56. doi: 10.1007/s11657-024-01413-3.
4
The evaluation of risk factors related to reduced bone mineral density in young people living with HIV.评估与 HIV 感染者年轻人骨密度降低相关的危险因素。
Afr Health Sci. 2022 Dec;22(4):461-469. doi: 10.4314/ahs.v22i4.52.
5
Bone Mineral Content Estimation in People Living with HIV: Prediction and Validation of Sex-Specific Anthropometric Models.HIV 感染者骨矿物质含量的估算:基于人体测量学的特定性别预测模型的建立与验证。
Int J Environ Res Public Health. 2022 Sep 28;19(19):12336. doi: 10.3390/ijerph191912336.
6
Bone Deleterious Effects of Different NRTIs in Treatment-naïve HIV Patients After 12 and 48 Weeks of Treatment.治疗初治 HIV 患者 12 周和 48 周后不同 NRTIs 的骨不良影响。
Curr HIV Res. 2021;19(5):434-447. doi: 10.2174/1570162X19666210805094434.
7
Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.在未接受抗逆转录病毒治疗的 HIV 感染成年男性中,与较低骨密度相关的风险因素增加。
BMC Infect Dis. 2021 Jun 9;21(1):542. doi: 10.1186/s12879-021-06263-9.
8
GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice gut-microbiota-dependent anti-inflammation.GG通过肠道微生物群依赖性抗炎作用减轻富马酸替诺福韦二吡呋酯诱导的雄性小鼠骨质流失。
Ther Adv Chronic Dis. 2019 Jul 3;10:2040622319860653. doi: 10.1177/2040622319860653. eCollection 2019.